B. Nguyen, R. Isaacs, H. Teppler, R. Leavitt, P. Sklar et al., Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium, Annals of the New York Academy of Sciences, vol.50, issue.1, pp.83-89, 2011.
DOI : 10.1111/j.1749-6632.2011.05972.x

S. Hare, S. Gupta, E. Valkov, A. Engelman, and P. Cherepanov, Retroviral intasome assembly and inhibition of DNA strand transfer, Nature, vol.25, issue.7286, pp.232-236, 2010.
DOI : 10.1038/nature08784

J. Mouscadet, O. Delelis, A. Marcelin, and L. Tchertanov, Resistance to HIV-1 integrase inhibitors: A structural perspective, Drug Resistance Updates, vol.13, issue.4-5, pp.139-150, 2010.
DOI : 10.1016/j.drup.2010.05.001

P. Quashie, T. Mesplede, and M. Wainberg, Evolution of HIV integrase resistance mutations, Current Opinion in Infectious Diseases, vol.26, pp.43-49, 2013.
DOI : 10.1097/QCO.0b013e32835ba81c

S. Hare, S. Smith, M. Métifiot, A. Jaxa-chamiec, Y. Pommier et al., Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572), Molecular Pharmacology, vol.80, issue.4
DOI : 10.1124/mol.111.073189

T. Mesplede, P. Quashie, N. Osman, Y. Han, D. Singhroy et al., Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure, Retrovirology, vol.10, issue.1, p.22, 2013.
DOI : 10.1038/nature08784

P. Cherepanov, G. Maertens, P. Proost, B. Devreese, J. Van-beeumen et al., HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells, Journal of Biological Chemistry, vol.278, issue.1, pp.372-381, 2003.
DOI : 10.1074/jbc.M209278200

P. Legrain, J. Rain, R. Benarous, S. Emiliani, C. Berlioz-torrent et al., Proteinprotein interactions in human immunodeficiency virus International publication number WO 03, 333346P Nov, vol.26, 2001.

A. Engelman and P. Cherepanov, The Lentiviral Integrase Binding Protein LEDGF/p75 and HIV-1 Replication, PLoS Pathogens, vol.4, issue.3, p.1000046, 2008.
DOI : 10.1371/journal.ppat.1000046.g004

K. Busschots, J. Vercammen, S. Emiliani, R. Benarous, Y. Engelborghs et al., The Interaction of LEDGF/p75 with Integrase Is Lentivirus-specific and Promotes DNA Binding, Journal of Biological Chemistry, vol.280, issue.18, pp.17841-17847, 2005.
DOI : 10.1074/jbc.M411681200

P. Cherepanov, A. Ambrosio, S. Rahman, T. Ellenberger, and A. Engelman, Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75, Proceedings of the National Academy of Sciences, vol.102, issue.48, pp.17308-17313, 2005.
DOI : 10.1073/pnas.0506924102

S. Hare, M. Shun, S. Gupta, E. Valkov, A. Engelman et al., A Novel Co-Crystal Structure Affords the Design of Gain-of-Function Lentiviral Integrase Mutants in the Presence of Modified PSIP1/LEDGF/p75, PLoS Pathogens, vol.81, issue.1, p.1000259, 2009.
DOI : 10.1371/journal.ppat.1000259.s005

M. Llano, D. Saenz, A. Meehan, P. Wongthida, M. Peretz et al., An Essential Role for LEDGF/p75 in HIV Integration, Science, vol.314, issue.5798, pp.461-464, 2006.
DOI : 10.1126/science.1132319

M. Shun, N. Raghavendra, N. Vandegraaff, J. Daigle, S. Hughes et al., LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration, Genes & Development, vol.21, issue.14, pp.1767-1778, 2007.
DOI : 10.1101/gad.1565107

A. Ciuffi, M. Llano, E. Poeschla, C. Hoffmann, J. Leipzig et al., A role for LEDGF/p75 in targeting HIV DNA integration, Nature Medicine, vol.17, issue.12, pp.1287-1289, 2005.
DOI : 10.1038/nm1329

S. Hare, D. Nunzio, F. Labeja, A. Wang, J. Engelman et al., Structural Basis for Functional Tetramerization of Lentiviral Integrase, PLoS Pathogens, vol.331, issue.7, p.1000515, 2009.
DOI : 10.1371/journal.ppat.1000515.s007

S. Emiliani, A. Mousnier, K. Busschots, M. Maroun, B. Van-maele et al., Integrase Mutants Defective for Interaction with LEDGF/p75 Are Impaired in Chromosome Tethering and HIV-1 Replication, Journal of Biological Chemistry, vol.280, issue.27, pp.25517-25523, 2005.
DOI : 10.1074/jbc.M501378200

F. Christ, A. Voet, A. Marchand, S. Nicolet, B. Desimmie et al., Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication, Nature Chemical Biology, vol.70, issue.6, pp.442-448, 2010.
DOI : 10.1038/nchembio.370

C. Yoakim, P. Deroy, M. Duplessis, A. Gagnon, S. Goulet et al., Preparation of pyrazolylbenzimidazole derivatives for use as HIV replication inhibitors, Boehringer Ingelheim International GmbH, pp.67644-67645, 2008.

Y. Tsantrizos, M. Bailey, F. Bilodeau, R. Carson, R. Coulombe et al., Preparation of 2-(tert-butyloxy)- 2-(2-methylquinolin-3-yl)acetic acid derivatives as inhibitors of human immunodeficiency virus replication, Boehringer Ingelheim International GmbH, pp.62285-62286, 2009.

C. Yoakim, M. Bailey, F. Bilodeau, R. Carson, L. Fader et al., Preparation of 2-alkoxy-2-(pyridin-3-yl)acetic acid derivatives as inhibitors of human immunodeficiency virus (HIV) replication. Boehringer Ingelheim International GmbH, pp.130034-130035, 2010.

C. Fenwick, R. Bethell, P. Bonneau, J. Duan, A. Faucher et al., Identification of BI-C, a Novel HIV-1 non- Catalytic Site Integrase Inhibitor, p.18, 2011.

M. Mitchell, P. Roethle, L. Xu, H. Yang, R. Mcfadden et al., Benzothiazole Compounds and Their Pharmaceutical use. US: Gilead Sciences Inc, pp.145728-145729, 2012.

P. Chaltin, Z. Debyser, M. De, A. Marchand, D. Marchand et al., Pyrimidine Derivatives as Novel Viral Replication Inhibitors and Their Preparation and use in the Treatment of HIV Infection

K. Babaoglu, K. Bjornson, H. Guo, R. Halcomb, J. Link et al., Naphth-2-yl)Acetic Acid Derivatives as HIV Antiviral Agents and Their Preparation and use for the Treatment of AIDS, pp.2-003497, 2012.

K. Babaoglu, K. Bjornson, H. Guo, R. Halcomb, J. Link et al., -(Quinolin-6-yl)Acetic Acid Derivatives as HIV Antiviral Agents and Their Preparation and use for the Treatment of AIDS. USA: Gilead Sciences, Inc, p.144

A. Bell, I. Gardner, K. Gibson, D. Pryde, and F. Wakenhut, Inhibitors of HIV Replication

S. Gerritz, D. Langley, G. Li, N. Meanwell, A. Pendri et al., Inhibitors of Human Immunodeficiency Virus Replication. US: Bristol Myers Squibb Co

M. De-la-rosa, S. Haidar, B. Johns, and E. Velthuisen, Isoquinoline Compounds and Methods for Treating HIV. US: Glaxo Smithkline LLC, pp.102985-102986, 2012.

S. Chasset, F. Chevreuil, B. Ledoussal, L. Strat, F. Benarous et al., Inhibitors of Viral Replication, Their Process of Preparation and Their Therapeutical Uses, Laboratoire Biodim, FR, pp.137181-137182, 2012.

S. Chasset, F. Chevreuil, B. Ledoussal, L. Strat, F. Benarous et al., Inhibitors of viral replication, their process of preparation and their therapeutical uses. Laboratoire Biodim FR 2012, pp.140243-140244

F. Christ, S. Shaw, J. Demeulemeester, B. Desimmie, A. Marchand et al., Small-Molecule Inhibitors of the LEDGF/p75 Binding Site of Integrase Block HIV Replication and Modulate Integrase Multimerization, Antimicrobial Agents and Chemotherapy, vol.56, issue.8, pp.4365-4374, 2012.
DOI : 10.1128/AAC.00717-12

M. Tsiang, G. Jones, A. Niedziela-majka, E. Kan, E. Lansdon et al., New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action, Journal of Biological Chemistry, vol.287, issue.25, pp.21189-21203, 2012.
DOI : 10.1074/jbc.M112.347534

J. Kessl, J. N. Koh, Y. Taskent-sezgin, H. Slaughter, A. Feng et al., Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors, Journal of Biological Chemistry, vol.287, issue.20, pp.16801-16811, 2012.
DOI : 10.1074/jbc.M112.354373

J. Demeulemeester, C. Tintori, M. Botta, Z. Debyser, and F. Christ, Development of an AlphaScreen-Based HIV-1 Integrase Dimerization Assay for Discovery of Novel Allosteric Inhibitors, Journal of Biomolecular Screening, vol.582, issue.5, pp.618-628, 2012.
DOI : 10.1021/jm901137j

F. Christ and Z. Debyser, The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy, Virology, vol.435, issue.1, pp.102-109, 2013.
DOI : 10.1016/j.virol.2012.09.033

H. Wang, K. Jurado, X. Wu, M. Shun, X. Li et al., HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor, Nucleic Acids Research, vol.40, issue.22, pp.11518-11530, 2012.
DOI : 10.1093/nar/gks913

L. Feng, A. Sharma, A. Slaughter, N. Jena, Y. Koh et al., The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors, Journal of Biological Chemistry, vol.288, issue.22, pp.15813-15820, 2013.
DOI : 10.1074/jbc.M112.443390

B. Desimmie, R. Schrijvers, J. Demeulemeester, D. Borrenberghs, C. Weydert et al., LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions, Retrovirology, vol.10, issue.1, p.57, 2013.
DOI : 10.1016/j.ab.2005.05.015

K. Jurado, H. Wang, A. Slaughter, L. Feng, J. Kessl et al., Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation, Proceedings of the National Academy of Sciences, vol.110, issue.21, pp.8690-8695, 2013.
DOI : 10.1073/pnas.1300703110

S. Yant, L. Tsai, O. Sullivan, C. Cihlar, T. Balakrishnan et al., Non-Catalytic Site Integrase Inhibitors Target the Integrase Domain During Virus Production and Induce a Reverse Transcription Block, Conference on Retroviruses and Opportunistic Infections. Gilead Sciences, 2013.

M. Balakrishnan, S. Yant, L. Tsai, O. Sullivan, C. Bam et al., Non-Catalytic Site HIV-1 Integrase Inhibitors Disrupt Core Maturation and Induce a Reverse Transcription Block in Target Cells, PLoS ONE, vol.8, issue.9, p.74163, 2013.
DOI : 10.1371/journal.pone.0074163.s002

Z. Hayouka, J. Rosenbluh, A. Levin, S. Loya, M. Lebendiker et al., Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium, Proceedings of the National Academy of Sciences, vol.104, issue.20, pp.8316-8321, 2007.
DOI : 10.1073/pnas.0700781104

C. Fenwick, S. Tremblay, E. Wardrop, R. Bethell, R. Coulombe et al., Resistance Studies with HIV-1 non-Catalytic Site Integrase Inhibitors, International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies, 2011.

J. Berg, B. Doe, K. Steimer, and M. Wabl, HeLa-LAV, an epithelial cell line stably infected with HIV-1, Journal of Virological Methods, vol.34, issue.2, pp.173-180, 1991.
DOI : 10.1016/0166-0934(91)90097-J

E. Guiot, K. Carayon, O. Delelis, F. Simon, P. Tauc et al., Relationship between the Oligomeric Status of HIV-1 Integrase on DNA and Enzymatic Activity, Journal of Biological Chemistry, vol.281, issue.32, pp.22707-22719, 2006.
DOI : 10.1074/jbc.M602198200
URL : https://hal.archives-ouvertes.fr/hal-00216092

A. Engelman, The Pleiotropic Nature of Human Immunodeficiency Virus Type 1 Integrase Mutations. In HIV-1 Integrase: Mechanism and Inhibitor Design, Drug Discovery and Development, pp.67-81

J. Wang, H. Ling, W. Yang, and R. Craigie, Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein, The EMBO Journal, vol.20, issue.24, pp.7333-7343, 2001.
DOI : 10.1093/emboj/20.24.7333

L. Berthoux, S. Sebastian, M. Muesing, and J. Luban, The role of lysine 186 in HIV-1 integrase multimerization, Virology, vol.364, issue.1, pp.227-236, 2007.
DOI : 10.1016/j.virol.2007.02.029

P. Lesbats, M. Metifiot, C. Calmels, S. Baranova, G. Nevinsky et al., In vitro initial attachment of HIV-1 integrase to viral ends: control of the DNA specific interaction by the oligomerization state, Nucleic Acids Research, vol.36, issue.22, pp.7043-7058, 2008.
DOI : 10.1093/nar/gkn796
URL : https://hal.archives-ouvertes.fr/hal-00426343

Y. Pommier and C. Marchand, Interfacial inhibitors: targeting macromolecular complexes, Nat Rev Drug Discov, vol.11, pp.25-36, 2012.

J. Condra, W. Schleif, O. Blahy, L. Gabryelski, D. Graham et al., In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors, Nature, vol.374, issue.6522, pp.569-571, 1995.
DOI : 10.1038/374569a0

M. Gonzales, E. Johnson, K. Dupnik, T. Imamichi, and R. Shafer, Colinearity of Reverse Transcriptase Inhibitor Resistance Mutations Detected by Population-Based Sequencing, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.34, issue.4, pp.398-402, 2003.
DOI : 10.1097/00126334-200312010-00006

O. Delelis, I. Malet, L. Na, L. Tchertanov, V. Calvez et al., The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation, Nucleic Acids Research, vol.37, issue.4, pp.1193-1201, 2009.
DOI : 10.1093/nar/gkn1050

A. Brussel and P. Sonigo, Analysis of Early Human Immunodeficiency Virus Type 1 DNA Synthesis by Use of a New Sensitive Assay for Quantifying Integrated Provirus, Journal of Virology, vol.77, issue.18, pp.10119-10124, 2003.
DOI : 10.1128/JVI.77.18.10119-10124.2003

F. Michel, C. Crucifix, F. Granger, S. Eiler, J. Mouscadet et al., Structural basis for HIV-1 DNA integration in the human genome, role of the LEDGF/P75 cofactor, The EMBO Journal, vol.269, issue.7, pp.980-991, 2009.
DOI : 10.1073/pnas.93.24.13659
URL : https://hal.archives-ouvertes.fr/inserm-00384501

F. Bushman, A. Engelman, I. Palmer, P. Wingfield, and R. Craigie, Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding., Proceedings of the National Academy of Sciences, vol.90, issue.8, pp.3428-3432, 1993.
DOI : 10.1073/pnas.90.8.3428

T. Jenkins, A. Hickman, F. Dyda, R. Ghirlando, D. Davies et al., Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues., Proceedings of the National Academy of Sciences, vol.92, issue.13, pp.6057-6061, 1995.
DOI : 10.1073/pnas.92.13.6057

F. Yu, G. Jones, M. Hung, A. Wagner, H. Macarthur et al., HIV-1 Integrase Preassembled on Donor DNA Is Refractory to Activity Stimulation by LEDGF/p75, Biochemistry, vol.46, issue.10, pp.2899-2908, 2007.
DOI : 10.1021/bi602387u

O. Delelis, V. Parissi, H. Leh, G. Mbemba, C. Petit et al., Efficient and Specific Internal Cleavage of a Retroviral Palindromic DNA Sequence by Tetrameric HIV-1 Integrase, PLoS ONE, vol.66, issue.7, p.608, 2007.
DOI : 10.1371/journal.pone.0000608.t001
URL : https://hal.archives-ouvertes.fr/hal-00211177

E. Potterton, P. Briggs, M. Turkenburg, and E. Dodson, 4 program suite, Acta Crystallographica Section D Biological Crystallography, vol.59, issue.7, pp.1131-1137, 2003.
DOI : 10.1107/S0907444903008126

S. Maignan, J. Guilloteau, Q. Zhou-liu, C. Clement-mella, and V. Mikol, Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases, Journal of Molecular Biology, vol.282, issue.2, pp.359-368, 1998.
DOI : 10.1006/jmbi.1998.2002

G. Murshudov, P. Skubak, A. Lebedev, N. Pannu, R. Steiner et al., 5 for the refinement of macromolecular crystal structures, Acta Crystallographica Section D Biological Crystallography, vol.57, issue.4, pp.355-367, 2011.
DOI : 10.1107/S0907444911001314

V. Lamzin, A. Perrakis, and K. Wilson, The ARP/WARP suite for automated construction and refinement of protein models The Netherlands: Kluwer Academic, In Int. Tables for Crystallography. Dordrecht, 2001.

G. Langer, G. Evrard, C. Carolan, and V. Lamzin, Fragmentation-Tree Density Representation for Crystallographic Modelling of Bound Ligands, Journal of Molecular Biology, vol.419, issue.3-4, pp.211-222, 2012.
DOI : 10.1016/j.jmb.2012.03.012

W. Delano, The PyMOL Molecular Graphics System, 2002.